Milestone Pharmaceuticals (MIST) Shares Outstanding (2018 - 2026)

Milestone Pharmaceuticals (MIST) has 9 years of Shares Outstanding (Entity) data on file, last reported at $117.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 120.32% year-over-year to $117.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117.8 million (up 120.32% YoY) and the FY2025 annual result came in at $83.9 million, up 57.22% from the prior year.
• Shares Outstanding (Entity) advanced to $117.8 million in Q1 2026, from $83.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $117.8 million in Q1 2026 to a low of $34.3 million in Q4 2022.
• A 5-year average of $55.3 million and a median of $53.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) declined 18.04% — and 2026, when it jumped 120.32%.
• Tracing MIST's Shares Outstanding (Entity) over 5 years: stood at $34.3 million in 2022, then gained by 25.29% to $43.0 million in 2023, then climbed by 24.21% to $53.4 million in 2024, then soared by 57.22% to $83.9 million in 2025, then surged by 40.43% to $117.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $117.8 million (Q1 2026), $83.9 million (Q4 2025), and $85.2 million (Q3 2025), per Business Quant data.